Cytek Biosciences (CTKB) Debt/Equity Ratio: History & Chart

Cytek Biosciences, Inc.(CTKB)

Medical - Devices · Fremont, CA

$6.13+0.04 (+0.66%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.

Fremont, CA

682 employees

cytekbio.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Wenbin Jiang

View full financials

CTKB Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.08

DEBT TO EQUITY RATIO AVG TTM

0.08

DEBT TO EQUITY RATIO AVG 3Y

0.06

DEBT TO EQUITY RATIO AVG 5Y

0.04

DEBT TO EQUITY RATIO AVG 10Y

N/A

DEBT TO EQUITY RATIO AVG 15Y

N/A

DEBT TO EQUITY RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-1.72%

CURRENT VS 3Y AVG

+47.63%

CURRENT VS 5Y AVG

+113.94%

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.14

median of 461 covered companies

CURRENT VS SECTOR MEDIAN

-41.30%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Cytek Biosciences, Inc. (CTKB)	$791.64M	0.08	0.08	0.06	0.04
AdaptHealth Corp. (AHCO)vs ›	$785.03M	1.50	1.31	1.32	1.45
Design Therapeutics, Inc. (DSGN)vs ›	$776.65M	0.01	0.01	0.01	0.01
Attovia Therapeutics, Inc. (ATTO)vs ›	$774.54M	0.04	0.01	0.01	0.01
InMode Ltd. (INMD)vs ›	$812.78M	0.01	0.01	0.01	0.01
Geron Corporation (GERN)vs ›	$769.83M	0.56	0.77	0.65	0.53
Avalo Therapeutics, Inc. (AVTX)vs ›	$766.41M	0.00	0.01	0.03	0.31
Gyre Therapeutics, Inc. (GYRE)vs ›	$825.02M	0.03	0.02	0.02	0.03
Candel Therapeutics, Inc. (CADL)vs ›	$756.15M	0.39	0.12	0.63	0.50
Ardelyx, Inc. (ARDX)vs ›	$837.43M	1.72	1.08	0.72	0.64

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Cytek Biosciences, Inc. (CTKB)

$791.64M

0.08

0.06

0.04

AdaptHealth Corp. (AHCO)vs ›

$785.03M

1.50

1.31

1.32

1.45

Design Therapeutics, Inc. (DSGN)vs ›

$776.65M

0.01

Attovia Therapeutics, Inc. (ATTO)vs ›

$774.54M

0.04

0.01

InMode Ltd. (INMD)vs ›

$812.78M

0.01

Geron Corporation (GERN)vs ›

$769.83M

0.56

0.77

0.65

0.53

Avalo Therapeutics, Inc. (AVTX)vs ›

$766.41M

0.00

0.01

0.03

0.31

Gyre Therapeutics, Inc. (GYRE)vs ›

$825.02M

0.03

0.02

0.03

Candel Therapeutics, Inc. (CADL)vs ›

$756.15M

0.39

0.12

0.63

0.50

Ardelyx, Inc. (ARDX)vs ›

$837.43M

1.72

1.08

0.72

0.64

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Cytek Biosciences, Inc. (CTKB)?

The debt to equity ratio for CTKB stock is 0.08.

Is Cytek Biosciences, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.08 is 114% above its 5-year average of 0.04, near the high end of its 5-year range (0.00–0.11).

What is the TTM average debt to equity ratio for Cytek Biosciences, Inc. (CTKB)?

The TTM average debt to equity ratio for CTKB stock is 0.08.

What is the 3Y average debt to equity ratio for Cytek Biosciences, Inc. (CTKB)?

The 3Y average debt to equity ratio for CTKB stock is 0.06.

What is the 5Y average debt to equity ratio for Cytek Biosciences, Inc. (CTKB)?

The 5Y average debt to equity ratio for CTKB stock is 0.04.

DATE	DEBT TO EQUITY RATIO
2026-06-30	0.08
2026-03-31	0.11
2025-12-31	0.07
2025-09-30	0.09
2025-06-30	0.06
2025-03-31	0.04
2024-12-31	0.04
2024-09-30	0.04
2024-06-30	0.04
2024-03-31	0.04
2023-12-31	0.04
2023-09-30	0.04
2023-06-30	0.04
2023-03-31	0.04
2022-12-31	0.04
2022-09-30	0.04
2022-06-30	0.04
2022-03-31	0.04
2021-12-31	0.00
2021-09-30	0.00
2021-06-30	0.00
2021-03-31	-0.18
2020-12-31	-0.17
2020-09-30	0.00
2020-06-30	0.00
2020-03-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

0.08

2026-03-31

0.11

2025-12-31

0.07

2025-09-30

0.09

2025-06-30

0.06

2025-03-31

0.04

2024-12-31

0.04

2024-09-30

0.04

2024-06-30

0.04

2024-03-31

0.04

2023-12-31

0.04

2023-09-30

0.04

2023-06-30

0.04

2023-03-31

0.04

2022-12-31

0.04

2022-09-30

0.04

2022-06-30

0.04

2022-03-31

0.04

2021-12-31

0.00

2021-09-30

0.00

2021-06-30

0.00

2021-03-31

-0.18

2020-12-31

-0.17

2020-09-30

0.00

2020-06-30

0.00

2020-03-31

0.00

Debt to Equity Ratio: 0.08

CTKB Debt to Equity Ratio

CTKB Average Debt to Equity Ratio Chart

CTKB Current vs Average Debt to Equity Ratio Chart

CTKB Debt to Equity Ratio Metrics

CTKB Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

CTKB Debt to Equity Ratio History

Related Metrics